Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007 | Review Article

Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause?

Authors: Ali Rezaie, Robyn D. Parker, Mohammad Abdollahi

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

Crohn’s disease (CD) and ulcerative colitis (UC), known as inflammatory bowel disease (IBD), are fairly common chronic inflammatory conditions of the gastrointestinal tract. Although the exact etiology of IBD remains uncertain, dysfunctional immunoregulation of the gut is believed to be the main culprit. Amongst the immunoregulatory factors, reactive oxygen species are produced in abnormally high levels in IBD. Their destructive effects may contribute to the initiation and/or propagation of the disease. We provided an extensive overview on the evidences from animal and human literature linking oxidative stress to IBD and its activity. Moreover, the effects of antioxidant therapy on IBD patients in randomized, controlled trials were reviewed and the need for further studies elaborated. We also summarized the evidence in support for causality of oxidative stress in IBD.
Literature
1.
go back to reference Brandtzaeg P, Haraldsen G, Rugtveit J (1997) Immunopathology of human inflammatory bowel disease. Semin Immunopathol 18(4):555–589CrossRef Brandtzaeg P, Haraldsen G, Rugtveit J (1997) Immunopathology of human inflammatory bowel disease. Semin Immunopathol 18(4):555–589CrossRef
2.
go back to reference Spitz DR, et al. (2004) Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23(3–4):311–322PubMedCrossRef Spitz DR, et al. (2004) Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23(3–4):311–322PubMedCrossRef
3.
go back to reference Mueller S (2000) Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems. Free Radic Biol Med 29(5):410–415PubMedCrossRef Mueller S (2000) Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems. Free Radic Biol Med 29(5):410–415PubMedCrossRef
4.
go back to reference Togashi H, et al. (2000) Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Radic Biol Med 28(6):846–853PubMedCrossRef Togashi H, et al. (2000) Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Radic Biol Med 28(6):846–853PubMedCrossRef
5.
go back to reference Faulkner K, Fridovich I (1993) Luminol and lucigenin as detectors for O2. Free Radic Biol Med 15(4):447–451PubMedCrossRef Faulkner K, Fridovich I (1993) Luminol and lucigenin as detectors for O2. Free Radic Biol Med 15(4):447–451PubMedCrossRef
6.
go back to reference Briggs RT, et al. (1986) Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 84(4–6):371–378PubMedCrossRef Briggs RT, et al. (1986) Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 84(4–6):371–378PubMedCrossRef
7.
go back to reference Pick E, Keisari Y (1980) A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38(1–2):161–170PubMedCrossRef Pick E, Keisari Y (1980) A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38(1–2):161–170PubMedCrossRef
8.
go back to reference Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142(2):231–255PubMedCrossRef Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142(2):231–255PubMedCrossRef
9.
go back to reference Collins AR, Horvathova E (2001) Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay. Biochem Soc Trans 29(Pt 2):337–341PubMedCrossRef Collins AR, Horvathova E (2001) Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay. Biochem Soc Trans 29(Pt 2):337–341PubMedCrossRef
10.
go back to reference Dalle-Donne I, et al. (2003) Protein carbonylation in human diseases. Trends Mol Med 9(4):169–176PubMedCrossRef Dalle-Donne I, et al. (2003) Protein carbonylation in human diseases. Trends Mol Med 9(4):169–176PubMedCrossRef
11.
go back to reference Hoffmann JC, et al. (2002) Animal models of inflammatory bowel disease: an overview. Pathobiology 70(3):121–130PubMedCrossRef Hoffmann JC, et al. (2002) Animal models of inflammatory bowel disease: an overview. Pathobiology 70(3):121–130PubMedCrossRef
12.
go back to reference Esworthy RS, et al. (2001) Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281(3):G848–855PubMed Esworthy RS, et al. (2001) Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281(3):G848–855PubMed
13.
go back to reference Forrest CM, et al. (2003) Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 527:395–400PubMed Forrest CM, et al. (2003) Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 527:395–400PubMed
14.
go back to reference Geerling BJ, et al. (1999) The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn’s disease and controls. Scand J Gastroenterol 34(11):1108–1116PubMedCrossRef Geerling BJ, et al. (1999) The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn’s disease and controls. Scand J Gastroenterol 34(11):1108–1116PubMedCrossRef
15.
go back to reference Genser D, et al. (1999) Status of lipidsoluble antioxidants and TRAP in patients with Crohn’s disease and healthy controls. Eur J Clin Nutr 53(9):675–679PubMedCrossRef Genser D, et al. (1999) Status of lipidsoluble antioxidants and TRAP in patients with Crohn’s disease and healthy controls. Eur J Clin Nutr 53(9):675–679PubMedCrossRef
16.
go back to reference Koutroubakis IE, et al. (2004) Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 49(9):1433–1437PubMedCrossRef Koutroubakis IE, et al. (2004) Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 49(9):1433–1437PubMedCrossRef
17.
go back to reference Wendland BE, et al. (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn’s disease. Am J Clin Nutr 74(2):259–264PubMed Wendland BE, et al. (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn’s disease. Am J Clin Nutr 74(2):259–264PubMed
18.
go back to reference Erichsen K, et al. (2003) Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn’s disease. Scand J Gastroenterol 38(5):543–548PubMedCrossRef Erichsen K, et al. (2003) Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn’s disease. Scand J Gastroenterol 38(5):543–548PubMedCrossRef
19.
go back to reference Holmes EW, et al. (1998) Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 43(5):1088–1095PubMedCrossRef Holmes EW, et al. (1998) Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 43(5):1088–1095PubMedCrossRef
20.
go back to reference Rezaie A, Eshghtork A, Zamani M, Dehghan G, Taghavi B, Nikfar S, Daryani N, Abdollahi M. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta1 in relation to disease activity in Crohn’s disease patients. Ann N Y Acad Sci (in press) Rezaie A, Eshghtork A, Zamani M, Dehghan G, Taghavi B, Nikfar S, Daryani N, Abdollahi M. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta1 in relation to disease activity in Crohn’s disease patients. Ann N Y Acad Sci (in press)
21.
go back to reference Miles AM, Grisham MB (1994) Antioxidant properties of aminosalicylates. Methods Enzymol 234:555–572PubMedCrossRef Miles AM, Grisham MB (1994) Antioxidant properties of aminosalicylates. Methods Enzymol 234:555–572PubMedCrossRef
22.
go back to reference Aghdassi E, et al. (2003) Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 98(2):348–353PubMed Aghdassi E, et al. (2003) Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 98(2):348–353PubMed
23.
go back to reference Trebble TM, et al. (2005) High-dose fish oil and antioxidants in Crohn’s disease and the response of bone turnover: a randomised controlled trial. Br J Nutr 94(2): 253–261PubMedCrossRef Trebble TM, et al. (2005) High-dose fish oil and antioxidants in Crohn’s disease and the response of bone turnover: a randomised controlled trial. Br J Nutr 94(2): 253–261PubMedCrossRef
24.
go back to reference Trebble TM, et al. (2004) Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 80(5):1137–1144PubMed Trebble TM, et al. (2004) Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 80(5):1137–1144PubMed
25.
go back to reference Geerling BJ, et al. (2000) Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn’s disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6(2):77–84PubMedCrossRef Geerling BJ, et al. (2000) Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn’s disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6(2):77–84PubMedCrossRef
26.
go back to reference Seidner DL, et al. (2005) An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3(4):358–369PubMedCrossRef Seidner DL, et al. (2005) An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3(4):358–369PubMedCrossRef
27.
go back to reference Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79–94PubMedCrossRef Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79–94PubMedCrossRef
28.
go back to reference Meyer CT, et al. (1981) Hydrogen peroxide colitis: a report of three patients. J Clin Gastroenterol 3(1):31–35PubMedCrossRef Meyer CT, et al. (1981) Hydrogen peroxide colitis: a report of three patients. J Clin Gastroenterol 3(1):31–35PubMedCrossRef
29.
go back to reference Bilotta JJ, Waye JD (1989) Hydrogen peroxide enteritis: the “snow white” sign. Gastrointest Endosc 35(5):428–430PubMedCrossRef Bilotta JJ, Waye JD (1989) Hydrogen peroxide enteritis: the “snow white” sign. Gastrointest Endosc 35(5):428–430PubMedCrossRef
30.
go back to reference Riedle B, Kerjaschki D (1997) Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am J Pathol 151(1):215–231PubMed Riedle B, Kerjaschki D (1997) Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am J Pathol 151(1):215–231PubMed
31.
go back to reference Rao RK, et al. (1997) Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 273(4 Pt 1):G812–G823PubMed Rao RK, et al. (1997) Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 273(4 Pt 1):G812–G823PubMed
32.
go back to reference Fries W, et al. (2005) Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn’s disease in Southern Italy. Am J Gastroenterol 100(12):2730–2736PubMedCrossRef Fries W, et al. (2005) Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn’s disease in Southern Italy. Am J Gastroenterol 100(12):2730–2736PubMedCrossRef
33.
go back to reference Buhner S, et al. (2006) Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 55(3):342–347PubMedCrossRef Buhner S, et al. (2006) Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 55(3):342–347PubMedCrossRef
34.
go back to reference Ding X, et al. (2005) Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci 96(3):157–163PubMedCrossRef Ding X, et al. (2005) Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci 96(3):157–163PubMedCrossRef
35.
go back to reference Tham DM, Whitin JC, Cohen HJ (2002) Increased expression of extracellular glutathione peroxidase in mice with dextran sodium sulfate-induced experimental colitis. Pediatr Res 51(5):641–646PubMed Tham DM, Whitin JC, Cohen HJ (2002) Increased expression of extracellular glutathione peroxidase in mice with dextran sodium sulfate-induced experimental colitis. Pediatr Res 51(5):641–646PubMed
36.
go back to reference Ardite E, et al. (2000) Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest 80(5):735–744PubMed Ardite E, et al. (2000) Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest 80(5):735–744PubMed
37.
go back to reference Nieto N, et al. (2000) Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 45(9):1820–1827PubMedCrossRef Nieto N, et al. (2000) Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 45(9):1820–1827PubMedCrossRef
38.
go back to reference Ghazanfari GMB, Yasa N, Ashtaral-Nakhai L, Mohammadirad A, Nikfar S, Dehghan G, Shetab-Boushehri V, Jamshidi H, Khorasani R, Salehnia A, Abdollahi M (2006) Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicology Mechanisms Methods 16(7):365–372CrossRefPubMed Ghazanfari GMB, Yasa N, Ashtaral-Nakhai L, Mohammadirad A, Nikfar S, Dehghan G, Shetab-Boushehri V, Jamshidi H, Khorasani R, Salehnia A, Abdollahi M (2006) Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicology Mechanisms Methods 16(7):365–372CrossRefPubMed
39.
go back to reference Ghafari HYN, Mohammadirad A, Dehghan G, Zamani MJ, Nikfar S, Khorasani S, Minaie B, Abdollahi M (2006 Jun) Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Human Experimental Toxicol 25:325–332CrossRef Ghafari HYN, Mohammadirad A, Dehghan G, Zamani MJ, Nikfar S, Khorasani S, Minaie B, Abdollahi M (2006 Jun) Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Human Experimental Toxicol 25:325–332CrossRef
40.
go back to reference Jahanshahi G, et al. (2004) Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 49(11–12):1752–1757PubMedCrossRef Jahanshahi G, et al. (2004) Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 49(11–12):1752–1757PubMedCrossRef
41.
go back to reference Barbosa DS, et al. (2003) Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19(10):837–842PubMedCrossRef Barbosa DS, et al. (2003) Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19(10):837–842PubMedCrossRef
42.
go back to reference Kruidenier L, et al. (2003) Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201(1):28–36PubMedCrossRef Kruidenier L, et al. (2003) Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201(1):28–36PubMedCrossRef
43.
go back to reference Tuzun A, et al. (2002) Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 35(7):569–572PubMedCrossRef Tuzun A, et al. (2002) Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 35(7):569–572PubMedCrossRef
44.
go back to reference Sampietro GM, et al. (2002) Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn’s disease. Dig Liver Dis 34(10):696–701PubMedCrossRef Sampietro GM, et al. (2002) Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn’s disease. Dig Liver Dis 34(10):696–701PubMedCrossRef
45.
go back to reference D’Odorico A, et al. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36(12):1289–1294PubMedCrossRef D’Odorico A, et al. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36(12):1289–1294PubMedCrossRef
46.
go back to reference Levy E, et al. (2000) Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn’s disease. Am J Clin Nutr 71(3):807–815PubMed Levy E, et al. (2000) Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn’s disease. Am J Clin Nutr 71(3):807–815PubMed
47.
go back to reference Chiarpotto E, et al. (1997) Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radic Biol Med 22(5):889–894PubMedCrossRef Chiarpotto E, et al. (1997) Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radic Biol Med 22(5):889–894PubMedCrossRef
48.
go back to reference Lih-Brody L, et al. (1996) Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41(10):2078–2086PubMedCrossRef Lih-Brody L, et al. (1996) Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41(10):2078–2086PubMedCrossRef
49.
go back to reference Cao W, et al. (2004) Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 286(5):G833–G843PubMedCrossRef Cao W, et al. (2004) Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 286(5):G833–G843PubMedCrossRef
50.
go back to reference Pelli MA, et al. (1999) Breath alkanes determination in ulcerative colitis and Crohn’s disease. Dis Colon Rectum 42(1):71–76PubMedCrossRef Pelli MA, et al. (1999) Breath alkanes determination in ulcerative colitis and Crohn’s disease. Dis Colon Rectum 42(1):71–76PubMedCrossRef
51.
go back to reference Hatoum OA, et al. (2003) Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125(1):58–69PubMedCrossRef Hatoum OA, et al. (2003) Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125(1):58–69PubMedCrossRef
52.
go back to reference Koch TR, et al. (2000) Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 45(9):1814–1819PubMedCrossRef Koch TR, et al. (2000) Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 45(9):1814–1819PubMedCrossRef
53.
go back to reference Tsunada S, et al. (2003) Redox imbalance in the colonic mucosa of ulcerative colitis. Scand J Gastroenterol 38(9):1002–1003PubMedCrossRef Tsunada S, et al. (2003) Redox imbalance in the colonic mucosa of ulcerative colitis. Scand J Gastroenterol 38(9):1002–1003PubMedCrossRef
54.
go back to reference Kruidenier L, et al. (2003) Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201(1):17–27PubMedCrossRef Kruidenier L, et al. (2003) Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201(1):17–27PubMedCrossRef
55.
go back to reference Szanto I, et al. (2005) Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207(2):164–176PubMedCrossRef Szanto I, et al. (2005) Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207(2):164–176PubMedCrossRef
56.
go back to reference Buffinton GD, Doe WF (1995) Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 19(6):911–918PubMedCrossRef Buffinton GD, Doe WF (1995) Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 19(6):911–918PubMedCrossRef
57.
go back to reference Reimund JM, et al. (2000) Antioxidant and immune status in active Crohn’s disease: a possible relationship. Clin Nutr 19(1):43–48PubMedCrossRef Reimund JM, et al. (2000) Antioxidant and immune status in active Crohn’s disease: a possible relationship. Clin Nutr 19(1):43–48PubMedCrossRef
58.
go back to reference Hoffenberg EJ, et al. (1997) Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr 65(5):1482–1488PubMed Hoffenberg EJ, et al. (1997) Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr 65(5):1482–1488PubMed
59.
go back to reference Fernandez-Banares F, et al. (1989) Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84(7):744–748PubMed Fernandez-Banares F, et al. (1989) Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84(7):744–748PubMed
60.
go back to reference Kuroki F, et al. (1993) Multiple vitamin status in Crohn’s disease. Correlation with disease activity. Dig Dis Sci 38(9):1614–1618PubMedCrossRef Kuroki F, et al. (1993) Multiple vitamin status in Crohn’s disease. Correlation with disease activity. Dig Dis Sci 38(9):1614–1618PubMedCrossRef
61.
go back to reference Hinks LJ, et al. (1988) Reduced concentrations of selenium in mild Crohn’s disease. J Clin Pathol 41(2):198–201PubMedCrossRef Hinks LJ, et al. (1988) Reduced concentrations of selenium in mild Crohn’s disease. J Clin Pathol 41(2):198–201PubMedCrossRef
Metadata
Title
Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause?
Authors
Ali Rezaie
Robyn D. Parker
Mohammad Abdollahi
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9622-2

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.